Browse the evidence

Acetate, a primary SCFA, crosses the blood-brain barrier to directly stimulate the hypothalamic arcuate nucleus, increasing POMC (anorexigenic) and decreasing AgRP (orexigenic) neuron expression.

Ensure adequate intake of fermentable fibers to generate acetate. While the direct brain effect is confirmed in animals, the practical application relies on the cumulative effect of high fiber intake.

In moderately obese men, elevated circulating free fatty acid (FFA) levels drive the accumulation of triglycerides within the myocardium and epicardial fat, a process that precedes left ventricular hypertrophy and overload.

For individuals with obesity, high levels of free fatty acids in the blood can lead to fat storage inside the heart muscle, even before heart function declines. This suggests that managing overall metabolic health and fatty acid availability is crucial for preventing early cardiac structural changes.

Consumption of wheat gliadin and plant lectins (found in grains, legumes, and some vegetables) increases intestinal permeability ('leaky gut'), leading to endotoxemia, chronic inflammation, and potentially autoimmune diseases and insulin resistance.

Be aware that wheat and legumes contain antinutrients like gliadin and lectins, which may increase gut permeability and inflammation in some individuals. If you experience digestive issues, autoimmune conditions, or insulin resistance, consider reducing or eliminating these foods and observe any changes in symptoms. Prioritize whole, unprocessed foods.

Metformin is a common pharmacological insulin sensitization therapy used to treat PCOS, though specific dosing protocols are not detailed in this review excerpt.

Metformin is a standard medication for treating insulin resistance in PCOS. Consult a doctor for appropriate dosing and monitoring.

Aging is a multifactorial biological process driven by interconnected molecular changes across genomics, epigenomics, transcriptomics, proteomics, and metabolomics, which can be mapped and potentially intervened upon through multi-omics analysis.

This paper does not provide a specific user protocol. It establishes that aging is a complex, multi-layered biological process involving genes, proteins, and metabolism, and that scientific databases exist to track these changes across species to develop interventions.

Geroprotective compounds (drugs) alter gene expression and regulation, providing a mechanism for lifespan and healthspan extension.

There are specific drugs (geroprotectors) that change gene expression to potentially extend healthspan. This database catalogs these drugs and their effects, helping researchers find potential treatments.

Experiencing weight bias in primary healthcare negatively influences patient engagement and utilization of health services, leading to avoidance or delay of care.

If you have obesity, you may face weight bias in healthcare, which can lead you to avoid or delay seeking care. This is a common and documented barrier. To overcome this, seek providers who focus on health behaviors rather than just weight, and remember that avoiding care due to fear of judgment can worsen health outcomes.

Ketone bodies (specifically beta-hydroxybutyrate) act as signaling molecules that inhibit histone deacetylases (HDACs) and promote histone acetylation, thereby altering gene expression to support anti-oxidant and anti-inflammatory pathways.

This is a deep molecular mechanism. Practically, it means that the ketone bodies your body makes on a low-carb diet are actively turning on genes that protect your cells from aging and damage.

Obstructive Sleep Apnea (OSA) is independently associated with glucose intolerance and insulin resistance, but OSA at baseline does not significantly predict the development of diabetes after adjusting for obesity.

Diagnose and treat OSA for cardiovascular and sleep quality benefits, but do not expect CPAP alone to resolve insulin resistance or diabetes in obese patients. Focus on weight management and lifestyle interventions for metabolic control.

Activation of the AMPK signaling pathway ameliorates fatty liver disease (FLD) by inhibiting lipid synthesis and promoting fatty acid oxidation.

Supporting liver health involves maintaining cellular energy balance. While specific dietary interventions are not detailed in this mechanism review, the activation of AMPK (often associated with energy deficit or exercise) is a key biological mechanism for reducing liver fat. Focus on metabolic health markers rather than just fat intake.

AMPK activation reduces liver fat accumulation by downregulating lipid synthesis genes (FAS, SREBP-1c, ACC, HMGCR) and upregulating fatty acid oxidation genes (CPT1, PGC1, HSL, ATGL).

Understanding the specific genes involved (like CPT1 for burning fat and FAS for making fat) helps explain why metabolic health is complex. Interventions that activate AMPK can shift this balance.

Ethanol consumption inhibits AMPK activity and reduces CPT1 expression, leading to fatty liver disease.

Chronic alcohol consumption disrupts the liver's ability to regulate fat metabolism by inhibiting AMPK. Reducing alcohol intake may help restore this regulatory pathway.

Sarcopenia and obesity in aging are linked to immune senescence through a common mechanism of decreased IL-15 (myokine) and increased pro-inflammatory adipokines, which negatively regulate Natural Killer (NK) cell survival and function.

Maintaining muscle mass through resistance training and managing body fat are critical for preserving immune function as you age. This is achieved by supporting healthy levels of IL-15 (from muscle) and reducing pro-inflammatory signals from fat tissue, which together protect Natural Killer cells.

L-carnitine supplementation may be beneficial for treating specific clinical conditions such as heart failure, angina, and oxidative stress, but routine use for general disorders is not yet recommended.

If you have heart conditions like angina or heart failure, L-carnitine might help reduce oxidative stress, but you should not take it routinely without medical advice, as more research is needed.

DNA methylation biomarkers in blood (e.g., ANK1, DAPK1, BDNF) are associated with Alzheimer's Disease (AD) risk and neuropathology, potentially enabling earlier detection.

If you have a family history of Alzheimer's, discuss emerging blood-based epigenetic biomarkers with your doctor. While not yet standard, these tests may offer earlier insights into risk, allowing for proactive lifestyle and medical management.

Acute administration of Vitamin C (2g oral) reverses noise-induced endothelial dysfunction, suggesting oxidative stress is the primary mechanism of noise-induced vascular damage.

While Vitamin C can acutely improve blood vessel function after noise stress, this does not replace the need to minimize noise exposure. Using antioxidants to mitigate the damage of chronic stress is a secondary strategy; primary prevention involves reducing the stressor (noise).

Delta sleep-inducing peptide (DSIP), uridine, oxidized glutathione, and muramyl peptides were identified as early 'sleep factors' through transfer experiments, but they lack a determined physiological sleep regulatory role compared to adenosine and PGD2.

Early research identified several substances like DSIP and uridine that could induce sleep when transferred between animals, but their natural role in regulating sleep in the body remains unclear compared to more recently identified factors like adenosine.

In patients with Nonalcoholic Steatohepatitis (NASH), improvement in hepatic steatosis (reduced intrahepatic triglyceride content) is associated with a specific shift in gut microbiota composition, characterized by a reduction in Firmicutes and an increase in Bacteroidetes.

If you have NASH, your gut bacteria composition is likely different from healthy individuals, specifically with lower levels of beneficial Firmicutes and higher Bacteroidetes. While taking probiotics alone did not significantly reduce liver fat in this study, the *shift* in your gut bacteria (more Bacteroidetes, less Firmicutes) correlates with better liver health. Focus on dietary patterns that support this microbial balance rather than relying on probiotic supplements alone.

In critically ill ICU patients without acute kidney injury, a higher Sarcopenia Index (serum creatinine divided by serum cystatin C multiplied by 100) is independently associated with lower hospital and 90-day mortality and shorter duration of mechanical ventilation.

For ICU patients without kidney failure, calculating the ratio of serum creatinine to cystatin C (multiplied by 100) provides a better estimate of muscle mass and predicts survival better than using creatinine alone or standard nutritional scores. This index can help identify high-risk patients for early intervention.

Gut microbiota depletion (via antibiotics or germ-free conditions) leads to muscle atrophy and reduced physical function, suggesting a causal link between microbiota presence and muscle maintenance.

This finding is primarily relevant for understanding the biological basis of muscle loss. For now, it supports the general importance of a healthy diet for gut microbiota, but does not yet justify specific interventions like antibiotics avoidance for muscle gain in healthy individuals.

Obesity-induced adipose tissue hypoxia and hypertrophy drive a pro-inflammatory adipokine profile (high leptin/TNF-a/IL-6, low adiponectin) that creates a permissive microenvironment for tumor initiation, progression, and metastasis.

Maintaining a healthy weight reduces the risk of obesity-related cancers by preventing the physiological state of adipose hypoxia and chronic inflammation. This involves managing body fat to avoid the hormonal imbalances (high leptin, low adiponectin) that fuel tumor growth.

Low levels of adiponectin, common in obesity, remove a protective anti-tumor effect, thereby facilitating cancer development and progression.

Improving adiponectin levels through weight management may help restore anti-tumor defenses. This involves reducing visceral fat to normalize adipokine secretion.

Elevated leptin levels in obesity promote cancer cell survival, proliferation, and migration by inducing anti-apoptotic, pro-inflammatory, and angiogenic factors.

Managing obesity helps lower leptin levels, which may reduce the stimulation of cancer cell growth and survival pathways.

Exposure to endocrine-disrupting chemicals (EDCs) during early development can alter adipose tissue homeostasis and energy regulation, predisposing individuals to obesity and metabolic syndrome even with low-calorie diets and increased physical activity.

If you are struggling with weight loss despite diet and exercise, consider your environmental exposure to endocrine disruptors (found in plastics, pesticides, and certain consumer products). While you cannot control all environmental factors, minimizing exposure to plastics (e.g., avoiding heating food in plastic) and choosing fresh over processed foods may support metabolic health, especially if you were exposed to these chemicals during early development.